​From Forgotten Waste to Diagnostics & Therapeutics 

​PART OF #JPMHealthTechWeek2026
Panel at SF HealthTech Summit | San Francisco

​Menstrual biology has long been overlooked. Today, it’s emerging as a powerful new input for biotech innovation.

​This expert panel explores how menstrual tissue and menstrual blood are being re-imagined across:

• ​Stem cell medicine & regenerative therapeutics

• ​Diagnostics & biomarker discovery

• ​Women’s health, fertility, inflammation, and longevity

• ​Platform biotech, biobanking, and scalable infrastructure

​We’ll discuss what it takes to turn a historically dismissed biological material into a credible, investable, and scalable biotech category — and why this shift matters now.

​Who should attend
Biotech and healthtech investors, founders, clinicians, scientists, and operators building at the frontier of women’s health and next-generation biology.

​Format
Curated expert panel + discussion
High-signal JPM-week networking

​
Panelists

• ​Juliette Humer — Founder & CEO, Muse Bio — Leading stem cell and regenerative platforms from menstrual biology.

• ​Ridhi Tariyal — Co-Founder, NextGen Jane — Pioneer of menstrual effluent–based molecular diagnostics.

• ​Olga Sazonova, Ph.D. — VP Computational Biology, Xella Health — Computational biology leader extracting health signals from menstrual fluid.

• ​Morgan M. Stanton — CEO & Founder, Opal Therapeutics — Building human-derived cell and organoid models for women’s health discovery.

• ​Mads Lillelund — Co-CEO, Qvin — Co-leading the scale-up of menstrual-based diagnostics and women’s health platforms.

• ​Michele Ferguson, MD — Chief Medical Officer, Muse Bio — Physician leading the clinical strategy for menstrual-derived stem cell therapeutics.
  

​Important Ticket Information:

• ​Panel Only is $30 that will have access to the summit for the panel only - paid luma ticket holder's names will be listed at the entrance of the HealthTech Summit

• ​Standard [HealthTeach Summit] entry is via an SF HealthTech Summit ticket — we’ve arranged a special partner discounted rate for our panel. Use code XELLA30 for 30% off HealthTech Summit Event pass and full access to our session.

• ​Please reach out if you need assistance in gaining access to this panel - we do not want a financial barrier to block attendance to our panel.

​

​About the Biotechs:

​Muse Bio is building the world's largest, most accessible stem cell and regenerative medicine platform to create better drugs, therapeutics and aesthetic products - all starting from menstrual blood — a powerful, renewable source of mesenchymal stem cells (MSCs). Donate and join our studies.

​NextGen Jane has built a proprietary human data and analytics engine for inflammatory and immune-mediated (I&I) disease by leveraging menstruation as a repeatable, longitudinal biological system. This novel aperture of interrogating inflammation biology enables pathway and target discovery, patient stratification, and measurement of treatment response across I&I conditions.

​Opal Therapeutics is building the first “uterus-in-a-dish” platform to fix a broken system: until now, women’s health R&D has relied on irrelevant mouse models. We're changing that. Our lab-grown uterine models deliver human data from day one, unlocking more accurate drug discovery, better outcomes for women, and major cost savings for pharma.

​
Xella Health is a women’s precision health and telemedicine company focused on transforming how women understand their biology across every life stage. Xella combines advanced multi-omic diagnostics, longitudinal data, and personalized clinician-led guidance to help women understand what’s happening in their bodies today—and what’s likely ahead.

​Qvin has created first FDA approved diabetes monitoring menstrual pad